alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › molecular

molecular

6 studies tagged molecular, dated 1992-10-01 to 2024-10-24. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis 2024-10-24
  2. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions 2020-12-01
  3. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings 2019-07-24

Studies

6 studies carry this tag.

Date range

1992 to 2024

Top journals

  • Biochemical and biophysical research communications 1
  • Molecular brain 1
  • Molecular neurobiology 1
  • Neurobiology of aging 1
  • Neurochemistry international 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Molecular neurobiology 2024-10-24 Biomarkers

    Alzheimer's disease (AD) is the most common form of dementia around the world (~ 65%).

  2. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Biochemical and biophysical research communications 2020-12-01 Biomarkers

    Formation of Aβ oligomers and fibrils plays a central role in the pathogenesis of Alzheimer's disease.

  3. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Progress in molecular biology and translational science 2019-07-24 Biomarkers

    Alzheimer's disease (AD) is very difficult to diagnose on pure clinical grounds, especially in the earlier phases of the disease.

  4. Blood-based molecular biomarkers for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Molecular brain 2019-03-28 Tau biomarkers

    A major barrier to the effective conduct of clinical trials of new drug candidates against Alzheimer's disease (AD) and to identifying patients for receiving future disease-modifying treatments is the limited capacity of the current health system to find and diagnose patients with early AD pathology.

  5. Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 1998-03-01 Tau biomarkers

    The ideal biomarker for Alzheimer's disease (AD) should detect a fundamental feature of neuropathology and be validated in neuropathologically-confirmed cases; it should have a sensitivity >80% for detecting AD and a specificity of >80% for distinguishing other dementias; it should be reliable, reproducible, non-invasive, simple to perform, and inexpensive.

  6. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurochemistry international 1992-10-01 Tau biomarkers

    The pattern of molecular forms of acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) separated by density gradient centrifugation was investigated in the brain and cerebrospinal fluid in Alzheimer's disease (AD), in human embryonic brain and in rat brain after experimental cholinergic deafferentation of the cerebral cortex.

All topic tags with their study counts